Detalhe da pesquisa
1.
Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population.
Eur Arch Otorhinolaryngol
; 272(12): 3779-84, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25510985
2.
Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations.
J BUON
; 20(2): 540-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26011347
3.
Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell line.
Am J Ther
; 21(6): 453-61, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25137407
4.
Different types of cell cycle- and apoptosis-related gene expressions alter in corticosteroid-, vincristine-, and melphalan-resistant u-266 multiple myeloma cell lines.
Turk J Haematol
; 31(3): 231-8, 2014 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25330516
5.
Association of -174G/C interleukin/6 gene polymorphism with the risk of chronic lymphocytic, chronic myelogenous and acute myelogenous leukemias in Turkish patients.
J BUON
; 19(3): 787-91, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25261668
6.
Differential synergistic effects of palbociclib and doxorubicin on doxorubicin-resistant cancer cells with diverse tumor origins.
J Chemother
; : 1-9, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664974
7.
Synthesis, Anticancer Activity, and In Silico Modeling of Alkylsulfonyl Benzimidazole Derivatives: Unveiling Potent Bcl-2 Inhibitors for Breast Cancer.
ACS Omega
; 9(8): 9547-9563, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38434899
8.
Investigation of the Therapeutic Effects of Palbociclib Conjugated Magnetic Nanoparticles on Different Types of Breast Cancer Cell Lines.
Cell Mol Bioeng
; 16(2): 143-157, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096074
9.
Drug metabolism and inflammation related distinct miRNA signature of colchicine resistant familial Mediterranean fever patients.
Int Immunopharmacol
; 124(Pt B): 111011, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844462
10.
Vancomycin Containing PDLLA and PLGA/ß-TCP Inhibit Biofilm Formation but Do Not Stimulate Osteogenic Transformation of Human Mesenchymal Stem Cells.
Front Surg
; 9: 885241, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846965
11.
Development of a microfluidic platform to maintain viability of micro-dissected tumor slices in culture.
Biomicrofluidics
; 16(3): 034103, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35547184
12.
Effect of cobalt-60 (γ radiation) on multidrug-resistant multiple myeloma cell lines.
Cell Biol Int
; 35(7): 721-5, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21241250
13.
Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug Delivery.
Anticancer Agents Med Chem
; 20(10): 1233-1240, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32156242
14.
Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients.
Cancer Invest
; 27(2): 201-5, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19235593
15.
Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
Anticancer Agents Med Chem
; 18(8): 1138-1147, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29532763
16.
Determination of the relationship between doxorubicin resistance and Wnt signaling pathway in HeLa and K562 cell lines.
EXCLI J
; 17: 386-398, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29805346
17.
Half generations magnetic PAMAM dendrimers as an effective system for targeted gemcitabine delivery.
Int J Pharm
; 515(1-2): 104-113, 2016 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27725272
18.
Loading of Gemcitabine on chitosan magnetic nanoparticles increases the anti-cancer efficacy of the drug.
Eur J Pharmacol
; 784: 121-8, 2016 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27181067
19.
An update on molecular biology and drug resistance mechanisms of multiple myeloma.
Crit Rev Oncol Hematol
; 96(3): 413-24, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26235594
20.
The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
Turk J Haematol
; 32(4): 311-6, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26376814